Clinical trial
An Open-Label, Randomized, Prospective Multicenter Study To Compare The Efficacy And Safety Among 3 Immunosuppressant Treatment Regimens In Patients Receiving A Liver Transplant For ESLD Caused By Chronic Hepatitis C
NCT00163657 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Randomized, Prospective Multicenter Study To Compare The Efficacy And Safety Among 3 Immunosuppressant Treatment Regimens In Patients Receiving A Liver Transplant For ESLD Caused By Chronic Hepatitis C
- Lead sponsor
- Baylor Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- January 31, 2007
- Enrollment
- 312 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.